Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy

J Nanobiotechnology. 2025 Jan 4;23(1):6. doi: 10.1186/s12951-024-03033-y.

Meng Wang^#^{1

2}, Qida Hu^#¹, Junmin Huang¹, Xinyu Zhao¹, Shiyi Shao¹, Fu Zhang^{1

3}, Zhuo Yao^{1

3}, Yuan Ping⁴, Tingbo Liang^{5

6

7

8

9}

¹ Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China.
² Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, 310003, China.
³ College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
⁴ College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. pingy@zju.edu.cn.
⁵ Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China. liangtingbo@zju.edu.cn.
⁶ Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, 310003, China. liangtingbo@zju.edu.cn.
⁷ Zhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Hangzhou, 310003, China. liangtingbo@zju.edu.cn.
⁸ Zhejiang Provincial Clinical Research Center for the Study of Hepatobiliary & Pancreatic Diseases, Hangzhou, 310003, China. liangtingbo@zju.edu.cn.
⁹ Cancer Center, Zhejiang University, Hangzhou, 310058, China. liangtingbo@zju.edu.cn.

^# Contributed equally.

No abstract available

Publication types